The OCUL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the OCUL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The OCUL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View OCUL Detailed Price Forecast - CNN Money | View OCUL Detailed Summary - Google Finance | ||
View OCUL Detailed Summary - Yahoo! Finance | View OCUL Stock Research & Analysis - Zacks.com |
View OCUL Trends & Analysis - Trade-Ideas | View OCUL Major Holders - Barrons | ||
View OCUL Call Transcripts - NASDAQ | View OCUL Breaking News & Analysis - Seeking Alpha | ||
View OCUL Annual Report - CompanySpotlight.com | View OCUL OTC Short Report - OTCShortReport.com | ||
View OCUL Fundamentals - TradeKing | View OCUL SEC Filings - Bar Chart | ||
View Historical Prices for OCUL - The WSJ | View Performance/Total Return for OCUL - Morningstar | ||
View the Analyst Estimates for OCUL - MarketWatch | View the Earnings History for OCUL - CNBC | ||
View the OCUL Earnings - StockMarketWatch | View OCUL Buy or Sell Recommendations - MacroAxis | ||
View the OCUL Bullish Patterns - American Bulls | View OCUL Short Pain Metrics - ShortPainBot.com |
View OCUL Stock Mentions - StockTwits | View OCUL Stock Mentions - PennyStockTweets | ||
View OCUL Stock Mentions - Twitter | View OCUL Investment Forum News - Investor Hub | ||
View OCUL Stock Mentions - Yahoo! Message Board | View OCUL Stock Mentions - Seeking Alpha |
View Insider Transactions for OCUL - SECform4.com | View Insider Transactions for OCUL - Insider Cow | ||
View OCUL Major Holdings Summary - CNBC | View Insider Disclosure for OCUL - OTC Markets | ||
View Insider Transactions for OCUL - Yahoo! Finance | View Institutional Holdings for OCUL - NASDAQ |
View OCUL Stock Insight & Charts - FinViz.com | View OCUL Investment Charts - StockCharts.com | ||
View OCUL Stock Overview & Charts - BarChart | View OCUL User Generated Charts - Trading View |
2 Small-Cap Growth Stocks With Room to Run
Posted on Wednesday April 24, 2024
These two small-cap growth stocks could be ready to run.
Ocular Therapeutix Highlights Early Data From Diabetes-Related Eye Disorder
Posted on Thursday April 18, 2024
On Thursday, Ocular Therapeutix Inc (NASDAQ:OCUL) announced topline results from the Phase 1 HELIOS study evaluating Axpaxli versus sham control in patients with moderately severe to severe non-proliferative diabetic retinopathy without diabetic macular edema (DME). 6 of 13 (46.2%) patients in the Axpaxli group experienced a 1 or 2-step improvement in the Diabetic Retinopathy Severity Scale (DRSS) at 40 weeks, with 2 of the 6 having a 2-step improvement. No patients in the control group showed 1
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
Posted on Thursday April 18, 2024
46.2% of patients demonstrated a 1- or 2-step improvement in the Diabetic Retinopathy Severity Scale (DRSS) at 40 weeks in the AXPAXLI arm, compared to 0% in the control arm No patients in the AXPAXLI group experienced worsening in DRSS compared to 12.5% in the control arm at 40 weeks AXPAXLI was generally well tolerated with no inflammation observed Ocular intends to present the Phase 1 HELIOS study at an upcoming meeting BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, In
The 3 Best Biotech Stocks to Buy Now: Q2 Edition
Posted on Tuesday April 16, 2024
Some of the hottest opportunities can be found in biotech stocks to buy now. With innovation, mergers and acquisitions, major companies looking to replenish their pipelines ahead of patent expirations, treatments for obesity, aging baby boomers, and demand for better care are creating massive opportunities. We’re even seeing big opportunities in cancer treatments known as ADCs (antibody-drug conjugates), and in gene-editing. We can even look at the impact artificial intelligence could have on he